Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01629030
Other study ID # 2012-05-067-001
Secondary ID
Status Recruiting
Phase N/A
First received June 25, 2012
Last updated July 8, 2014
Start date June 2012
Est. completion date December 2014

Study information

Verified date July 2014
Source Samsung Medical Center
Contact Sangmin M. Lee, MD, PhD
Phone 82-2-3410-0362
Email sangminm.lee@samsung.com
Is FDA regulated No
Health authority South Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

The investigators are trying to evaluate the performance of neutrophil and lymphocyte counts as a risk factor of deep sternal wound infection after coronary artery bypass graft surgery.


Description:

Deep sternal wound infection after coronary artery bypass graft is a very dangerous complication as it prolongs hospital stay, increase morbidity and mortality, and increase cost of care.

As a risk factor of surgical site infection, risk index reported by NNIS (national nosocomial infection surveillance), Euroscore, or Society of thoracic surgeon risk score are currently used. However, as various performances are reported regarding these index or scoring systems, and many factors are needed for these index or scoring system, there is a need to develop a more simple risk factor with better performance. We focused on the differential blood cell count, as the neutrophil and lymphocyte count are related to the degree of surgical invasion, and inflammatory response. Previous studies reported that the neutrophilia or lymphopenia is related to postoperative infection. Therefore, we are trying to evaluate the performance of preoperative or postoperative the blood cell differential count as a risk factor for sternal wound infection after coronary artery bypass surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 1850
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria:

- Those underwent coronary artery bypass graft surgery with median sternotomy in Samsung Medical Center during the period of January 2008 and December 2011.

Exclusion Criteria:

- Those underwent coronary artery bypass graft surgery with mini-thoracotomy

- Those with insufficient study data recognized by electronic medical record

Study Design

Time Perspective: Retrospective


Locations

Country Name City State
Korea, Republic of Samsung Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative surgical wound infection postoperative surgical wound infection within first week after the end of coronary artery bypass graft surgery, classified as a superfical or deep sternal wound infection within first week after the end of coronary artery bypass graft surgery No
Secondary preoperative total leukocyte count preoperative total leukocyte count 1 day before surgery No
Secondary preoperative neutrophil count preoperative neutrophil count 1 day before surgery No
Secondary preoperative lymphocyte count preoperative lymphocyte count 1 day before surgery No
Secondary postoperative total leukocyte count postoprative total leukocyte count 2 hour after the end of surgery No
Secondary postoperative neutrophil count postoperative neutrophil count 2 hour after the end of surgery No
Secondary postoperative lymphocyte count postoperative lymphocyte count 2 hour after the end of surgery No
Secondary preoperative NNIS risk index preoperative NNIS risk index 1 day before surgery No
Secondary preoperative EuroScore preoperative EuroScore 1 day before surgery No
Secondary Preoperative STS Preoperative STS (Society of Thoracic Surgeons risk score) 1 day before surgery No
Secondary the incidence of surgical reopen with surgical wound infection the incidence of surgical reopen with surgical wound infection within 1 month after surgery No
See also
  Status Clinical Trial Phase
Completed NCT01688648 - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft N/A
Completed NCT01596738 - Tranexamic Acid in On-pump CABG With Premature Clopidogrel Cessation N/A
Completed NCT00965471 - Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease N/A
Completed NCT05058222 - Effect of Deep Breathing Exercises on Post Operative Sleep Duration N/A
Completed NCT03299101 - Pilot Testing a Home-Based Rehabilitation Intervention Designed to Improve Outcomes of Frail Veterans Following Cardiothoracic Surgery N/A
Completed NCT01535222 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery Phase 2
Completed NCT00863044 - High Frequency Ventilation During Off Pump Coronary Artery Bypass Graft (CABG) Phase 4
Completed NCT01932008 - Evaluation of the Bone Mineral Density and Muscle Mass in Patients Post Coronary Artery Bypass Graft Surgery With Chronic Kidney Disease N/A
Completed NCT05349773 - The Pneumatic Tourniquet Technique for Endoscopic Radial Artery Harvest; Does it Affect Patient Hemodynamics?
Completed NCT03424382 - CREATION Health Readmission Risk Assessment Tool
Not yet recruiting NCT05706545 - Micro- and Macro-Circulation in Cardiac Surgery Patients
Completed NCT01572454 - Comparison of Dexmedetomidine and Remifentanil Infusion During CABG N/A
Completed NCT04993976 - Prehabilitation and Coronary Artery Bypass Grafting N/A
Completed NCT04310995 - Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts Phase 4
Completed NCT03925493 - Exercise Prescription in Cardiac Rehabilitation N/A
Not yet recruiting NCT04485143 - Cloud-based ECG Monitoring and Healthcare Model Building on the Population With Coronary Artery Revascularization
Recruiting NCT04231461 - Quality of Life After Cardiac Surgery
Completed NCT03002129 - FLuid Responsiveness Prediction Using EXtra Systoles N/A
Completed NCT01591642 - Physical Activity, Functional Fitness and Quality of Life After Coronary Artery Bypass Grafting N/A
Completed NCT00048308 - Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass Phase 3